Skip to main content
Clinical Trials/NCT07569302
NCT07569302Not yet recruitingPhase 2

Triggering Ovulation in Normo-responders Using a Modified Dual Trigger Protocol or HCG Trigger . A Randomized Controlled Study

Bedaya Hospital1 site in 1 country196 target enrollmentStarted: June 1, 2026Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Phase 2
Status
Not yet recruiting
Sponsor
Enrollment
196
Locations
1

Study Overview

Brief Summary

The aim of this randomized controlled study is to compare the efficacy of a modified dual trigger protocol [a single bolos of HCG combined with two successive doses of a GnRH agonist ] with HCG [a single bolos administered 36 hours before oocyte retrieval ] in triggering ovulation in normo-responders undergoing ovarian stimulation using the antagonist protocol.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 40 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • GnRH antagonist IVF cycle
  • Normo-responders to induction of ovulation

Exclusion Criteria

  • Hypogonadotrophic hypogonadism
  • Endometriosis
  • History of recurrent abortion

Arms & Interventions

Modified dual trigger group

Experimental

HCG is administered 36 hours before ovum pickup and two successive doses of GnRH are administered 36 and 24 hours before ovum pickup.

Intervention: Modified dual trigger (Drug)

HCG group

Active Comparator

A single dose of HCG is administered 36 hours before oocyte retrieval

Intervention: HCG (Drug)

Investigators

Sponsor
Bedaya Hospital
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials